Cancer cells generate protons (H + ) that are extruded to the extracellular medium mainly via the Na + /H + exchanger 1 (NHE1), which regulates intracellular pH (pHi) and cell proliferation. In primary cultures of human ascites-derived ovarian cancer cells (haOC) we assayed whether NHE1 was required for pHi modulation and cell proliferation. Human ovary expresses NHE1, which is higher in haOC and A2780 (ovarian cancer cells) compared with HOSE cells (normal ovarian cells). Basal pHi and pHi recovery (following a NH 4 Cl pulse) was higher in haOC and A2780, compared with HOSE cells. Zoniporide (NHE1 inhibitor) caused intracellular acidification and pHi recovery was independent of intracellular buffer capacity, but reduced in NHE1 knockdown A2780 cells. Zoniporide reduced the maximal proliferation capacity, cell number, thymidine incorporation, and ki67
Introduction
Ovarian cancer is frequently diagnosed at advanced stages [1, 2] . Cancer cells generate protons (H + ) [3] , which are released by membrane transport systems resulting in low extracellular pH (pHo), i.e., acidity, but high intracellular pH (pHi), i.e., alkalization [4] . The membrane transport systems involved in pHi control include the sodium (Na + )/H + exchangers (NHEs) [5] [6] [7] [8] . NHE isoform 1 (NHE1) predominates and plays critical roles in cancer [4, [8] [9] [10] . NHE1 activity causes intracellular alkalization and extracellular acidification [4, 11] . Since NHE1 inactivation reduces proliferation of human tumour gastric
[12] and small lung cancer [13] cells, NHE1 may act as a pro-proliferative factor in human tumour cells.
Mechanisms of pHi control in the human ovary or ascites-cancer cells are unknown [8] . Since non-human ovary cells exhibit NHEs activity [14] [15] [16] [17] [18] , NHE1 may control the pHi in the human ovary. However, there are not reports addressing expression or activity of NHE1 in human ovarian cancer cells [8] . In this study, we show that functional NHE1 is expressed in human ovarian cancer cells playing a critical role in pHi recovery and cell proliferation. Thus, NHE1 expression and activity are factors that could result in pHidependent modulation of human ovarian cancer cells proliferation. The latter could be relevant to the reduced survival of patients suffering from this disease.
Materials and methods

Study groups
Patients included in this study (3 patients) coursed with ovarian cancer (high degree of ovarian serous papillary carcinoma stage IIIC or IV, and endometrioid mix type carcinoma with high degree serous differentiation) and were all subjected to primary
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7 period the cells were rinsed with phosphate-buffered salt (PBS) solution ((mmol/L) NaCl 130, KCl 2.7, Na 2 HPO 4 0.8, KH 2 PO 4 1.4 (pH 7.4, 4ºC)) and exposed to 5% trichloroacetic acid (TCA, 200 mL, 10 minutes). TCA was removed and cells rinsed with 99% methanol (200 mL) and digested with 25 mmol/L formic acid for radioactivity determination as described [21] .
Measurement of pHi
Cell monolayers in 96 well plates (70% confluence) were incubated for 10 minutes at 37°C with the fluorescent pH sensitive probe 2,7-bicarboxyethyl-5,6-carboxyfluorescein acetoxymethyl ester (BCECF-AM, 12 mol/L) (Sigma-Aldrich), as described [22] . Some experiments were also performed in cells incubated for 1 minute with BCECF-AM, and the results for pHi were not significantly different from 10 minutes incubation (not shown).
The excess of probe was removed by rinse three times with control solution (CS) 2, or 8.2)) as described [21, 22] . Cells were incubated without or with 5 μmol/L 5-N,N-hexamethylene amiloride (HMA, NHEs general inhibitor) [23] , 100 nmol/L zoniporide [20] , 0.1 µmol/L concanamycin A (V type ATPases (V-ATPases) inhibitor) [24] , and 10 µmol/L Schering 28080 (H + /K + ATPase inhibitor) [25] .
Recovery of pH i
The pH i recovery was examined by applying the NH 4 Cl pulse technique [21, 22] Recovery rates of pH i (dpHi/dt) were calculated from data collected for the first 60 seconds of the recovery (i.e., after removing the NH 4 Cl load) and fitted by a first order lineal regression as described [21, 22] . The results were expressed in pH i units/minute. The
NHEs-mediated component of dpHi/dt ( NHEs f) was estimated from: Initial velocity for pHi recovery was derived from slope of linear phase of dpHi/dt adjusted to the one phase exponential association equation considering the least squares fit [26] :
where v i is initial velocity, dpHi/dt is mayor recovery rate at a given time (t) (in this study t = 0.03 seconds) and e and k are constants. The capacity of cells to change the pHi value in certain units of pHi as a result in the dpHi/dt modifications (i.e., efficiency of pHi modulation (1/ pHi E)) was estimated from:
where dpHi/dt is the change in dpHi/dt from control, pHi is the change in pHi from control, and  is a given pHi unit.
Intrinsic buffering capacity
The ability of intrinsic cellular components to buffer changes in pHi, i.e., intracellular buffer capacity (i), was measured as described [21] . After determining the basal pHi the cells were incubated in a 0.5 mmol/L KCl-containing 0 Na + /CS plus Schering A C C E P T E D M A N U S C R I P T 
Western blotting
Total protein was obtained from confluent cells rinsed (x2) with ice-cold PBS and harvested in 100 µL of lysis buffer (100 mmol/L NaCl, 10 mmol/L Na 4 P2O 7 x10-H 2 O, 10 mmol/L NaF, 1% Triton X100, 1 mmol/L sodium orthovanadate, 50 mg/mL leupeptin, 20 mmol/L HEPES (pH 7.4, 4ºC) as described [22] . Cells were sonicated (6 cycles, 5 seconds, 
Immunofluorescence microscopy
Paraformaldehyde-fixed, paraffin-embedded ovarian cancer serial sections (4 µm)
were dewaxed and subsequently rehydrated with serial incubations using 100, 95, or 70% Cells were grown on microscope cover glasses (6 x10 4 cells per slide) (Sail Brand, Shangai, China) in corresponding culture media to 70% confluence as described [27] . In brief, cells were fixed (4% paraformaldehyde, 15 minutes), permeabilized (0.1% Triton X-100, 10 minutes) and blocked (PBS/2% BSA, 1 hour, 22ºC). NHE1 and ki67 were Total Fluorescence Intensity (CTCF) as described [28] in regions of optical interest (ROI) in serial slices. ROI was defined as a section of the tissue that was positive (epithelial) or negative (stroma) for the epithelial marker CK-7 where NHE1 and ki67 staining was determined. Images were processed with Image J version 1.48v (Wayne Rusband NIH, USA).
NHE1 suppression
Suppression of NHE1 expression was done using the commercially available short interference RNAs (siRNA) NHE-1 siRNA (h) or control sequence (siC) (Santa Cruz Biotechnology) following manufacturer's instructions 
Statistical analysis
The values are mean ± S.E.M., where n indicates the number of different biological samples (3 ascites from patients with ovarian cancer) and corresponding cell cultures with 
Results
NHE1 expression in human ovary
The first goal of this study was to determine whether NHE1 was expressed in human ovarian cancer tissue. Ovarian cancer tissue was positive for NHE1 and CK7
( Figure 1A ). NHE1 was detected in tumour epithelium and stroma ( Figure 1B) , with higher fluorescence at the epithelium, compared with stroma ( Figure 1C ). We then assayed whether NHE1 was expressed in cultured human ovarian cancer cells. NHE1 protein was detected in all cell types ( Figure 2A ) and was higher in haOC and A2780 compared with HOSE cells. NHE1 protein was detected in the cells and in the cell periphery ( Figure 2B ).
Basal pHi and dpHi/dt
Since NHE1 expression associates with pHi modulation in several tumour cells [4- 10], we determined basal pHi and the potential functional involvement of this and other membrane transport mechanisms to regulate intracellular H + content. Basal pHi in haOC and A2780 was higher than in HOSE cells (Table 1) . Zoniporide and HMA, but not concanamycin A or Schering 28080 caused intracellular acidification in all cell types. To estimate the capacity of cells to recover from an acidic pHi cells were subjected to the NH 4 Cl pulse assay [21] [22] [23] . The acidic pHi caused by the NH 4 Cl pulse was fully restored after ~3 minutes ( Figure 3A) . Basal dpHi/dt (Table 1) 
ßi and J H+
Since a change in basal pHi and dpHi/dt depends on the ßi capacity of cells [21] , this parameter was estimated and used to determine J H+ . The results show that ßi increased as pHi value decreased ( Figure 3C ) and ßi at equal pHi after a 20 mmol/L NH 4 Cl pulse (pHi HOSE = 6.95, pHi haOC = 6.93, pHi A2780 = 6.95) were similar in all cell types ( Figure 3D ). In addition, J H + was higher in haOC and A2780 compared with HOSE cells ( Figure 3E ). With the aim to corroborate that NHE1 expression is required for a pHi recovery, cells knockdown for this protein were used to estimate dpHi/dt. The NHE1 protein abundance was lower in KD-NHE1 HOSE and KD-NHE1 A2780 cells compared with cells
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expressing NHE1 ( Figure 4C ). The KD-NHE1 HOSE and KD-NHE1 A2780 cells also show lower dpHi/dt compared with cells expressing NHE1 ( Figure 4D ).
Cell proliferation and NHE1 and ki67 correlation
Since an acidic pHo due to increased activity of NHE1 is associated with increased tumour cells proliferation [12,13], cell proliferation was assayed in the presence of a NHE1
inhibitor. The results show that zoniporide reduced proliferation ( Figure 5A ) and the K/D t in all cell types ( Table 2 To confirm a parallel increase in NHE1 and ki67 protein expression in human ovarian tissue, a potential correlation between these proteins expression was analysed. The results show that NHE1 and ki67 proteins were detected in the same regions in ovarian cancer tissues, with a positive correlation for NHE1 and ki67 protein abundances ( Figure   5C ). Additionally, the cell number counted in KD-NHE1 HOSE and
KD-NHE1
A2780 cells was lower compared with these cells expressing NHE1 ( Figure 5D ).
SLC9A1 and overall survival
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In the aim of knowing whether NHE1 overexpression associates with adverse prognostic in patients with high-grade serous ovarian cancer, we analysed in silico the DNA copy-number alterations (CAN) for SLC9A1. Analysis of the CNA for this gene in human ovarian cancer reveals that 4% of cases will present with genetic changes including amplification (nine patients), deep deletions (one patients), and upregulation (six patients) or downregulation (two patients) of mRNA expression ( Figure 6A ). SLC9A1 mRNA expression increases according to the type of CNA alteration in patients with high-serous ovarian cancer ( Figure 6B ). The analysis in silico reveals that SLC9A1 is in direct-pathway There was not a difference between amplification and homologous deletions (5 patients, Log-rank = 0.36, Wilcoxon = 0.68), or homologous deletion and overall survival when compared with unaltered or mild CNA alteration.
Discussion
This study shows that NHE1 is expressed in the human ovarian cancer and primary cultures of human ascites ovarian cancer cells (haOC cells (~31 (mmol/L)/pHi units) [22, 35] , and lower than in non-tumour MDCK cells (~110 (mmol/L)/pHi units) [21] . The differences in the βi values could be due to specie differences (human versus dog) since the experimental conditions to determine this parameter were similar in these studies.
HMA reduced the dpHi/dt and pHi, suggesting a role for NHEs in these phenomena.
Since HMA-reduced pHi was higher (~1.5 fold) in haOC than non-tumour cells, haOC cells are more sensitive to NHEs activity-dependent pHi regulation. Same results were found in cells treated with zoniporide. Thus, haOC cells require NHE1 activity by a larger fraction ( NHE1 f / NHEs f ~0.8), in this phenomenon. NHE1 f involvement to increase pHi is supported by the lower dpHi/dt detected in NHE1-knockdown ovarian tumour cells. [36] [37] [38] . Interestingly, a high pHi favours the transition from phase S to G2/M in the cell cycle and DNA/RNA synthesis [6, 39] . Our results show that zoniporide reduced 
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Parallel analysis of CNA in SLC9A1 (for NHE1) revealed that a fraction of patients showed with CNA including higher amplification. Since SLC9A1 mRNA expression is increased depending on CNA alterations, this change in SLC9A1 could determine human ovarian cancer stage. CNA alterations may modulate the SLC9A1 expression by endothelin-1 and epidermal growth factor, complementing reports involving endothelin-1 and endothelin receptor A in this type of cancer [40] and endothelin-1 in combination with -arrestin-1 activation increasing chemoresistance [41] . Equally, activation of epidermal growth factor/epidermal growth factor receptor signalling is involved in higher angiogenesis [42] and resistance to paclitaxel [43] showing that inhibition of NHE1 activity results in a higher sensitivity to paclitaxel in breath cancer [47] . Thus, strategies to control NHE1 expression and activity in patients with ovary cancer could be of benefit reducing the adverse patient's outcome of this disease.
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